Outlook Therapeutics, Inc. Annual Income Tax Expense (Benefit) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Outlook Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2015 to 2023.
  • Outlook Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $2.8K, unchanged year-over-year.
  • Outlook Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $2.8K, unchanged from 2022.
  • Outlook Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $2.8K, a 40% increase from 2021.
  • Outlook Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $2K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.8K $0 0% Oct 1, 2022 Sep 30, 2023 10-K 2023-12-22
2022 $2.8K +$800 +40% Oct 1, 2021 Sep 30, 2022 10-K 2023-12-22
2021 $2K +$3.27M Oct 1, 2020 Sep 30, 2021 10-K 2022-12-29
2020 -$3.27M +$139K +4.08% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-23
2019 -$3.41M +$237K +6.5% Oct 1, 2018 Sep 30, 2019 10-K 2020-12-23
2018 -$3.65M -$6.8M -216% Oct 1, 2017 Sep 30, 2018 10-K 2019-12-19
2017 $3.15M +$3.05M +2958% Jan 1, 2017 Dec 31, 2017 10-Q 2018-08-14
2016 $103K +$293K Oct 1, 2015 Sep 30, 2016 10-K 2017-12-29
2015 -$190K Oct 1, 2014 Sep 30, 2015 10-K 2016-12-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.